Promotional Features

Content provided BY Clinical Ink

Handling complexity in GI trials ⁠— a purpose-built eCOA/ePRO solution

The accelerating complexity of gastroenterology protocols has exceeded the capacity of most electronic clinical outcome assessments (eCOAs) to adapt.

Content provided BY PRA Health Sciences

Challenges Arise as the Need for Pediatric Research Increases

With pediatric clinical trials increasing with the RACE Act, we need to consider the hurdles that will be faced when it comes to enrollment, costs, and trial design.

Content provided BY Merck KGaA, Darmstadt, Germany

Challenges in choosing the correct HPLC/LC-MS column for biologics characterization?

Industry pipelines and portfolios have changed significantly, in recent years, with the small molecules that used to dominate increasingly giving way to biologics.

Content provided BY Clinical Ink

Accelerating Database Lock: Adaptive Design & Remote Monitoring

CASE STUDY: A pharmaceutical company conducting a Phase III study of an investigational ointment required an eSource solution that could support remote monitoring, video uploads, and image capture and provide push-button randomization.

Content provided BY Yourway

Protecting Clinical Trials in Wake of COVID-19

In an unprecedented time of worldwide disruption, Yourway helps you navigate the critical supply chain journey for successful clinical trial development, execution, and conclusion.

Content provided BY Advarra

Managing Research Risks During an Emerging Infectious Diseases Event: A Coronavirus Case Study

The news is filled with stories about the novel 2019 coronavirus (2019-nCov or SARS-CoV-2). Emerging infectious diseases are part of the reality of a globalized civilization

Content provided BY Federal Equipment Company

Investment Recovery: Partnering for Surplus Asset Management

Companies that want to recover their investment in equipment assets are better positioned if they have a comprehensive plan in place before the surplus is evident

Content provided BY Clinical Ink

SUCCEED WITH BYOD FOR ePRO IN ANY PHASE OF CLINICAL RESEARCH

As more and more people own smart phones, bring your own device (BYOD) patient data collection often makes sense. What are the risks and opportunities presented by such a strategy?

Content provided BY Marken

How personalized medicines are disrupting the supply chain

Sponsors for a Phase 2 clinical trial needed an expensive, time-sensitive therapy transported to investigator sites at -80º C. Further, when reaching out to cryogenic shipper rental companies, the sponsor found they often transport regionally and do not...

Content provided BY Dätwyler Sealing Solutions International

Datwyler's Starter Pack - A Single Source Solution for Drug Discovery Through Drug Delivery

Datwyler Sealing Solutions is a leading industrial supplier and a key player in the global healthcare industry. The Swiss-based company offers state-of-the-art solutions for parenteral packaging and medical devices, built on more than 100 years of experience....

Content provided BY Yourway

Tracking your Project from Packaging Line to Patient

Supporting the delivery of clinical trial materials requires more than a logistics service provider. Clinical trials are growing in number and complexity. More trials are dispersed over many locations in different countries of the world with varying regulations...

Content provided BY Merck KGaA, Darmstadt, Germany

Improve the efficiency of your impurity testing

Improve the efficiency of your impurity testing with ready-to-use pharmaceutical impurity solutions manufactured as ISO approved Certified Reference Materials (CRMs)

Content provided BY Marken

Marken Advances Critical Supply Chain

Cell and gene therapies are the next-generation healthcare protocols, and the human trials into their efficacies are rising. An advanced supply chain solutions provider is the key to success.

Content provided BY Advarra

Who Needs to Comply With the Revised Common Rule and What Does It Mean for Informed Consent Forms?

Most requirements for the revised Common Rule are in effect. This article serves as a guide for researchers who are still unsure if they need to comply or what that means when it comes to informed consent form (ICF) requirements.

Content provided BY Marken

Mastering clinical drug distribution in an era of advanced therapies and global trials

The composition of clinical trial pipelines is changing quickly as the rise of advanced therapies adds another layer to the multi-decade shift from small molecules to biologics. This change is fueling once-unimaginable advances in the treatment of cancers,...

Promotional Features

Handling complexity in GI trials ⁠— a purpose-built eCOA/ePRO solution

Challenges Arise as the Need for Pediatric Research Increases

Challenges in choosing the correct HPLC/LC-MS column for biologics characterization?

Accelerating Database Lock: Adaptive Design & Remote Monitoring

Protecting Clinical Trials in Wake of COVID-19

Managing Research Risks During an Emerging Infectious Diseases Event: A Coronavirus Case Study

Investment Recovery: Partnering for Surplus Asset Management

SUCCEED WITH BYOD FOR ePRO IN ANY PHASE OF CLINICAL RESEARCH

How personalized medicines are disrupting the supply chain

Datwyler's Starter Pack - A Single Source Solution for Drug Discovery Through Drug Delivery

Tracking your Project from Packaging Line to Patient

Improve the efficiency of your impurity testing

Marken Advances Critical Supply Chain

Who Needs to Comply With the Revised Common Rule and What Does It Mean for Informed Consent Forms?

Mastering clinical drug distribution in an era of advanced therapies and global trials

Follow us

Products

Webinars

Headlines

Free newsletter sign up

Outsourcing-Pharma

Resources